GlassScriptPhysician profile
Randolph Jackson Ross
NPI 1295267680
$5,040.18
in general payments reported to CMS, 2019-2025
29 companies · $1,753 in 2025
The $1,753 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.97 · 2020: $16.38 · 2021: $306 · 2022: $561 · 2023: $698 · 2024: $1,693 · 2025: $1,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,142.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $974.81 | 2020-2025 | Tezspire, Fasenra, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $554.28 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Glaxosmithkline, LLC. | $434.87 | 2022-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $315.42 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $271.18 | 2022-2025 | Dupixent |
| Mylan Specialty L.P. | $252.77 | 2023-2024 | Yupelri |
| Intuitive Surgical, INC. | $225.09 | 2024 | |
| Ani Pharmaceuticals, INC. | $224.14 | 2024-2025 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $202.17 | 2025 | Yupelri |
| Grifols USA, LLC | $200.50 | 2025 | Prolastin-C Liquid |
| Electromed, INC. | $196.49 | 2023-2025 | Smartvest |
| Pfizer INC. | $173.74 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $146.32 | 2022-2024 | Zerbaxa, Winrevair, Recarbrio |
| Verona Pharma, INC. | $109.49 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $96.18 | 2024-2025 | Tyvaso, Tyvaso |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $84.63 | 2025 | |
| Mallinckrodt Hospital Products INC. | $79.56 | 2024-2025 | Acthar |
| Shionogi INC | $78.56 | 2023-2025 | Fetroja |
| Insmed, INC. | $71.94 | 2022-2024 | Arikayce |
| Actelion Pharmaceuticals US, INC. | $53.06 | 2023 | Opsumit, Uptravi |
| Axsome Therapeutics, INC. | $48.47 | 2023 | Sunosi |
| Inari Medical, INC. | $45.43 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Baxter Healthcare | $44.96 | 2024 | Hillrom - Vest System Model 105 Home Care |
| La Jolla Pharmaceutical Company | $36.43 | 2024-2025 | Giapreza |
| Amgen INC. | $32.82 | 2024 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $25.18 | 2024 | Glassia |
| Philips North America LLC | $23.18 | 2023 | |
| Liquidia Technologies, INC. | $20.07 | 2025 | Yutrepia |
| Pulmonx Corporation | $18.44 | 2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randolph Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.